News Release 2020 November 27, 2020 Kyorin Pharmaceutical Receives Marketing Approval for injectable New Quinolone Antibacterial Agent "Lasvic® Intravenous Drip Infusion Kit 150mg" October 12, 2020 KYORIN assigns Intellectual Properties regarding KRP-203 to Priothera September 30, 2020 Notice regarding the joint development and commercialization agreement for [AKP-009], a treatment agent for Benign Prostatic Hyperplasia August 3, 2020 KYORIN and Otonomy Signed License Agreement for Novel Candidate Compound for Sensorineural Hearing Loss June 29, 2020 Kyorin Pharmaceutical obtains approval for additional indication for pediatric use of Flutiform® 50 Aerosol, a combination drug for asthma treatment March 31, 2020 Release of Novel Coronavirus Detection Reagent "SARS-CoV-2 GeneSoC ER Kyorin" January 6, 2020 KYORIN and aTyr to Collaborate on Novel Immunomodulator 1